# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY DEVICE ONLY TEMPLATE

A. 510(k) Number: k050024   
B. Purpose for Submission: New Device   
C. Measurands: Amphetamine, Barbiturates, Benzodiazepines, Marijuana, Cocaine, Methadone, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Opiates, Phencyclidine, and Tricyclic Antidepressants   
D. Type of Test: Qualitative immunoassay   
E. Applicant: Guangzhou Wondfo Biotech Co, Ltd.   
F. Proprietary and Established Names: One Step Urine Test for Amphetamine, Barbiturates, Benzodiazepines, Cannabinoids, Cocaine, Methadone, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Opiates, Phencyclidine, and Tricyclic Antidepressants. One Step Multi-Drug Urine Test Panel

# G. Regulatory Information:

1. Regulation section: 21 CFR 862.3100, 862.3150, 862.3170, 862.3870, 862.3250, 862.3620, 862.3610, 862.3640, 862.3650, 862.3910   
2. Classification: All class II   
3. Product Codes: DKZ, DIS, JXM, LDJ, DIO, DJR, DJC, DPK, DJG, LCM, LFG   
4. Panel: Toxicology (91)

# H. Intended Use:

1. Intended use(s): Refer to Indications for use.   
2. Indication(s) for use: One Step Multiple Drugs of Abuse Assays is used for the qualitative determination of the following drugs of abuse in urine: Product Name Cutoff Amphetamine (amphetamine) 1000 ng/ml Barbiturates (secobarbital) 300 ng/ml Benzodiazipines (oxazepam) 300 ng/ml Cocaine (benzoylecgonine) 300 ng/ml Methamphetamine (methamphetamine) 1000 ng/ml Morphine (morphine) 300 ng/ml Opiates (morphine) 2000 ng/ml Methadone (methadone) 300 ng/ml Methylenedioxymethamphetamine 500 ng/ml (methylenedioxymethamphetamine)   
Phencyclidine (phencyclidine) 25 ng/ml Tricyclic antidepressant drugs 1000 ng/ml (nortriptyline)   
Cannabinoids 50 ng/ml (tetrahydrocannabinol-COOH)

The configurations of the One Step Multiple Drugs of Abuse Assays are available in any combination of the above tests. These devices are intended to be used by healthcare professionals only. For in vitro diagnostic use. Measurements obtained by this device are used in the diagnosis and treatment of use or overdose of the drugs listed above.

This assay provides only a preliminary result. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly in evaluating a preliminary positive result. To obtain a confirmed analytical result, a more specific alternate chemical method is needed. Gas chromatography/mass spectroscopy (GC/MS) is the recommended confirmatory method.

3. Special condition for use statement(s):

The Guangzhou Wondfo assay provides only a preliminary analytical test result. A more specific alternative chemical method must be used to obtain a confirmed analytical result. Gas chromatography/Mass spectrometry is the preferred confirmatory method. Other chemical confirmation methods are available. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.

The assay is not designated for use in point-of-care settings.

Tests for barbiturates, benzodiazepines, opiates, and tricyclic antidepressants cannot distinguish between abused drugs and certain prescribed medications.

Certain foods or medications may interfere with tests for amphetamines and opiates and cause false positive results.

# 4. Special instrument Requirements:

Not applicable. The devices are visually read single-use devices.

# I. Device Description:

The sponsor has included data from three different configurations, all of which use the same strip(s). One configuration is a single-use dipstick device. Operators dip the test strip into the urine and the reaction is initiated by movement of the sample through the test strip. The second configuration combines from 2 to 12 strips in a multi-drug urine test panel. Operators dip the test strips into the urine and the reaction is initiated by movement of the sample through the test strips. The third configuration uses the same strips in a cassette format. Operators add several drops of the sample to the sample well. The test reaction is initiated by movement of the sample through the test strip.

# J. Substantial Equivalence Information:

1. Predicate device name(s): ACON, Inc One Step Drug Screening Test Card   
2. Predicate K number(s): K020771

# 3. Comparison with predicate:

Both devices are for the qualitative determination of the same analyte(s) in the same matrix, and utilize the same cutoff concentration. Both are visually-read single use devices. The reagent formulations vary between the two devices.

<table><tr><td rowspan=4 colspan=3>SimilaritiesItem                       Device                                            PredicateCalibrator                                                           Amphetamine (d-amphetamine)Methamphetamine (d-methamphetamine)Cocaine (Benzoylecgonine)Cannabinoids (11-nor-delta-9-THC-9-COOH)Phencyclidine (Phencyclidine)Same                        Morphine (Morphine)Opiates (Morphine)Methadone (Methadone)Barbiturates (Secobarbital)Benzodiazepines (Oxazepam)</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate</td></tr><tr><td rowspan=2 colspan=1>Calibrator</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Antibodies</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>Mouse, Monoclonal</td></tr><tr><td rowspan=1 colspan=1>Methodology</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>Qualitative Lateral Flow Immunochromatographic</td></tr><tr><td rowspan=1 colspan=1>Internal Control</td><td rowspan=1 colspan=1>Same</td><td rowspan=1 colspan=1>Procedural control indicates adequate sample volumeand integrity of the strip</td></tr><tr><td rowspan=1 colspan=2></td><td rowspan=1 colspan=1>Differences</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate</td></tr><tr><td rowspan=1 colspan=1>Calibrator</td><td rowspan=1 colspan=1>TCA (Nortryptyline)MDMA(Methylenedioxymethamphetamine)</td><td rowspan=1 colspan=1>TCA, MDMA not included</td></tr><tr><td rowspan=1 colspan=1>Point of Care Use</td><td rowspan=1 colspan=1>No</td><td rowspan=1 colspan=1>Yes</td></tr><tr><td rowspan=1 colspan=1>Configurations</td><td rowspan=1 colspan=1>Strip, Cassette, Multi-Drug Test Panel</td><td rowspan=1 colspan=1>Test Card, Test Card with Integrated Cup</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

The sponsor did not reference any standards in their submission.

# L. Test Principle:

The test employs lateral flow immunochromatographic technology.

Drug in the sample and drug-labeled conjugate (containing a chromagen) compete for antibody binding sites in the test area of the test strip. Binding of drug in the sample causes the absence of a line at the test area, i.e., a positive result. When drug is not present in the sample, the drug-labeled conjugate binds at the test line, resulting in formation of a line, i.e., a negative result. The absence or presence of the line is determined visually by the operator.

The device also has an internal process control which indicates that an adequate volume of sample has been added and that the immunochromatographic strip is intact.

Description of the test antibodies: monoclonal mouse antibody against damphetamine, d-methamphetamine, Benzoylecgonine, 11-nor-delta-9-THC-9-COOH, Phencyclidine, Morphine (for both the morphine and opiates assay), Methadone, Secobarbital, Oxazepam, Nortryptyline, and Methylenedioxymethamphetamine.

Description of the control line antibody: Polyclonal Goat anti-Mouse

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

# a. Precision/Reproducibility:

To assess the precision of the device, the sponsor used both spiked and clinical samples. The spiked samples were prepared at the following concentrations: cutoff – $50 \%$ , cutoff – $2 5 \%$ , cutoff, cutoff $+ 2 5 \%$ , and the cutoff $+ 5 0 \%$ . All samples were analyzed with GCMS to confirm the concentration. Each concentration was then tested using three lots of the candidate device. For each drug, thirty samples (five clinical and 25 spiked) were analyzed at each concentration, and each result was read by three viewers, for a total of 90 results per concentration per lot. See summary data below.

Specimen description: drug free urine spiked with d-amphetamine, d-methamphetamine, benzoylecgonine, 11-nor-delta-9-THC-9-COOH, phencyclidine, morphine (for both the morphine and opiates assay), methadone, secobarbital, oxazepam, nortryptyline, and methylenedioxymethamphetamine. The sponsor also used clinical samples containing the same compounds. The study protocol was the same for all 12 analytes:

Number of days: one   
Replicates per day: at each concentration, 90 replicates per lot   
Lots of product used: three   
Number of operators: three   
Operator: laboratorian   
Testing Facility: manufacturer

Results of the studies are presented below:

# Cocaine Precision Study Results

Lot 1   

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>82/8</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>53/37</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>13/77</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

Lot 3   

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>80/10</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>36/54</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>13/77</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>80/10</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>36/54</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>13/77</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

# Barbiturates Precision Study Results

Lot 1   
  

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>79/11</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>42/48</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>18/72</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>79/11</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>42/48</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>18/72</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

Lot 3   

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>79/11</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>42/48</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>18/72</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

# Cannabinoid (THC) Precision Study Results Lot 1

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>38</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>76/14</td></tr><tr><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>43/47</td></tr><tr><td rowspan=1 colspan=1>63</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>12/78</td></tr><tr><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

Lot 3   

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>38</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>76/14</td></tr><tr><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>43/47</td></tr><tr><td rowspan=1 colspan=1>63</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>12/78</td></tr><tr><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>38</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>76/14</td></tr><tr><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>43/47</td></tr><tr><td rowspan=1 colspan=1>63</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>12/78</td></tr><tr><td rowspan=1 colspan=1>75</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

# Opiates Precision Study Results

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>80/10</td></tr><tr><td rowspan=1 colspan=1>2000</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>44/46</td></tr><tr><td rowspan=1 colspan=1>2500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>12/78</td></tr><tr><td rowspan=1 colspan=1>3000</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

Lot 3   

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>80/10</td></tr><tr><td rowspan=1 colspan=1>2000</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>44/46</td></tr><tr><td rowspan=1 colspan=1>2500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>12/78</td></tr><tr><td rowspan=1 colspan=1>3000</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>80/10</td></tr><tr><td rowspan=1 colspan=1>2000</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>44/46</td></tr><tr><td rowspan=1 colspan=1>2500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>12/78</td></tr><tr><td rowspan=1 colspan=1>3000</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

PCP Precision Study Results Lot 1   
Lot 2   

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>93/7</td></tr><tr><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>47/43</td></tr><tr><td rowspan=1 colspan=1>32</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>14/76</td></tr><tr><td rowspan=1 colspan=1>38</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

Lot 3   

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>93/7</td></tr><tr><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>47/43</td></tr><tr><td rowspan=1 colspan=1>32</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>14/76</td></tr><tr><td rowspan=1 colspan=1>38</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>93/7</td></tr><tr><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>47/43</td></tr><tr><td rowspan=1 colspan=1>32</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>14/76</td></tr><tr><td rowspan=1 colspan=1>38</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

# Amphetamine Precision Study Results

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>78/12</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>32/58</td></tr><tr><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>14/76</td></tr><tr><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>78/12</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>32/58</td></tr><tr><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>14/76</td></tr><tr><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>78/12</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>32/58</td></tr><tr><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>14/76</td></tr><tr><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

TCA Precision Study Results Lot 1   
  

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>78/12</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>41/49</td></tr><tr><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>13/77</td></tr><tr><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

Lot 3   

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>78/12</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>41/49</td></tr><tr><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>13/77</td></tr><tr><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>78/12</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>41/49</td></tr><tr><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>13/77</td></tr><tr><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

# Benzodiazepines Precision Study Results

<table><tr><td rowspan=1 colspan=1>concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>79/11</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>41/49</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>9/81</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>79/11</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>41/49</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>11/79</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

Lot 3   

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>80/10</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>41/49</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>11/79</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

# Morphine Precision Study Results

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>77/13</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>28/62</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>8/82</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>77/13</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>28/62</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>8/82</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

Lot 3   

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>77/13</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>28/62</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>6/84</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

# Methadone Precision Study Results

Lot 1   
  

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>75/15</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>41/49</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>7/83</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>75/15</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>41/49</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>7/83</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

Lot 3   

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>75/15</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>41/49</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>7/83</td></tr><tr><td rowspan=1 colspan=1>450</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

# MDMA Precision Study Results

Lot 1   
  

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>325</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>86/14</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>30/50</td></tr><tr><td rowspan=1 colspan=1>625</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>9/81</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

Lot 3   

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>325</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>86/14</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>30/50</td></tr><tr><td rowspan=1 colspan=1>625</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>9/81</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>325</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>86/14</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>30/50</td></tr><tr><td rowspan=1 colspan=1>625</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>9/81</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

# Methamphetamine Precision Study Results

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>81/9</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>34/56</td></tr><tr><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>13/77</td></tr><tr><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>81/9</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>34/56</td></tr><tr><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>13/77</td></tr><tr><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Concentration of sample,ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Results# Neg/ #Pos</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>81/9</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>34/56</td></tr><tr><td rowspan=1 colspan=1>1250</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>13/77</td></tr><tr><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

The sponsor also conducted a bridging study to demonstrate comparable performance between the strip format and the cassette format. Note: the multi-strip format is not housed in plastic but consists of multiple strips with a holder. Since these are dipped and read in the same manner as the single dipsticks, they were not included in the bridging study.

Amphetamines Bridging Study   

<table><tr><td rowspan=1 colspan=1>Concentration</td><td rowspan=1 colspan=1>Strip Results(neg/pos)</td><td rowspan=1 colspan=1>Cassette Results(neg/pos)</td><td rowspan=1 colspan=1>% Agreement</td></tr><tr><td rowspan=1 colspan=1>Cutoff -25%</td><td rowspan=1 colspan=1>59/1</td><td rowspan=1 colspan=1>59/1</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>98</td></tr><tr><td rowspan=1 colspan=1>Cutoff + 25%</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>98</td></tr></table>

Barbiturates Bridging Study   

<table><tr><td rowspan=1 colspan=1>Concentration</td><td rowspan=1 colspan=1>Strip Results(neg/pos)</td><td rowspan=1 colspan=1>Cassette Results(neg/pos)</td><td rowspan=1 colspan=1>% Agreement</td></tr><tr><td rowspan=1 colspan=1>Cutoff -25%</td><td rowspan=1 colspan=1>59/1</td><td rowspan=1 colspan=1>59/1</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>98</td></tr><tr><td rowspan=1 colspan=1>Cutoff + 25%</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>98</td></tr></table>

Benzodiazepines Bridging Study   

<table><tr><td rowspan=1 colspan=1>Concentration</td><td rowspan=1 colspan=1>Strip Results(neg/pos)</td><td rowspan=1 colspan=1>Cassette Results(neg/pos)</td><td rowspan=1 colspan=1>% Agreement</td></tr><tr><td rowspan=1 colspan=1>Cutoff -25%</td><td rowspan=1 colspan=1>59/1</td><td rowspan=1 colspan=1>59/1</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>98</td></tr><tr><td rowspan=1 colspan=1>Cutoff + 25%</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>98</td></tr></table>

Cocaine Bridging Study   

<table><tr><td rowspan=1 colspan=1>Concentration</td><td rowspan=1 colspan=1>Strip Results(neg/pos)</td><td rowspan=1 colspan=1>Cassette Results(neg/pos)</td><td rowspan=1 colspan=1>% Agreement</td></tr><tr><td rowspan=1 colspan=1>Cutoff -25%</td><td rowspan=1 colspan=1>59/1</td><td rowspan=1 colspan=1>60/0</td><td rowspan=1 colspan=1>98</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>2/58</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>97</td></tr><tr><td rowspan=1 colspan=1>Cutoff + 25%</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>98</td></tr></table>

MDMA Bridging Study   

<table><tr><td rowspan=1 colspan=1>Concentration</td><td rowspan=1 colspan=1>Strip Results(neg/pos)</td><td rowspan=1 colspan=1>Cassette Results(neg/pos)</td><td rowspan=1 colspan=1>% Agreement</td></tr><tr><td rowspan=1 colspan=1>Cutoff -25%</td><td rowspan=1 colspan=1>60/0</td><td rowspan=1 colspan=1>58/2</td><td rowspan=1 colspan=1>97</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>98</td></tr><tr><td rowspan=1 colspan=1>Cutoff + 25%</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>98</td></tr></table>

Marijuana Bridging Study   

<table><tr><td rowspan=1 colspan=1>Concentration</td><td rowspan=1 colspan=1>Strip Results(neg/pos)</td><td rowspan=1 colspan=1>Cassette Results(neg/pos)</td><td rowspan=1 colspan=1>% Agreement</td></tr><tr><td rowspan=1 colspan=1>Cutoff -25%</td><td rowspan=1 colspan=1>58/2</td><td rowspan=1 colspan=1>60/0</td><td rowspan=1 colspan=1>97</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Cutoff + 25%</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>98</td></tr></table>

# Methamphetamine Bridging Study

Morphine Bridging Study   

<table><tr><td rowspan=1 colspan=1>Concentration</td><td rowspan=1 colspan=1>Strip Results(neg/pos)</td><td rowspan=1 colspan=1>Cassette Results(neg/pos)</td><td rowspan=1 colspan=1>% Agreement</td></tr><tr><td rowspan=1 colspan=1>Cutoff -25%</td><td rowspan=1 colspan=1>59/1</td><td rowspan=1 colspan=1>60/0</td><td rowspan=1 colspan=1>98</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>98</td></tr><tr><td rowspan=1 colspan=1>Cutoff + 25%</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>98</td></tr></table>

Methadone Bridging Study   

<table><tr><td rowspan=1 colspan=1>Concentration</td><td rowspan=1 colspan=1>Strip Results(neg/pos)</td><td rowspan=1 colspan=1>Cassette Results(neg/pos)</td><td rowspan=1 colspan=1>% Agreement</td></tr><tr><td rowspan=1 colspan=1>Cutoff -25%</td><td rowspan=1 colspan=1>59/1</td><td rowspan=1 colspan=1>59/1</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Cutoff + 25%</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>98</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Concentration</td><td rowspan=1 colspan=1>Strip Results(neg/pos)</td><td rowspan=1 colspan=1>Cassette Results(neg/pos)</td><td rowspan=1 colspan=1>% Agreement</td></tr><tr><td rowspan=1 colspan=1>Cutoff -25%</td><td rowspan=1 colspan=1>59/1</td><td rowspan=1 colspan=1>59/1</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>2/58</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>97</td></tr><tr><td rowspan=1 colspan=1>Cutoff + 25%</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>98</td></tr></table>

Opiates Bridging Study   

<table><tr><td rowspan=1 colspan=1>Concentration</td><td rowspan=1 colspan=1>Strip Results(neg/pos)</td><td rowspan=1 colspan=1>Cassette Results(neg/pos)</td><td rowspan=1 colspan=1>% Agreement</td></tr><tr><td rowspan=1 colspan=1>Cutoff -25%</td><td rowspan=1 colspan=1>59/1</td><td rowspan=1 colspan=1>60/0</td><td rowspan=1 colspan=1>98</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>98</td></tr><tr><td rowspan=1 colspan=1>Cutoff + 25%</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>98</td></tr></table>

Phencyclidine Bridging Study   

<table><tr><td rowspan=1 colspan=1>Concentration</td><td rowspan=1 colspan=1>Strip Results(neg/pos)</td><td rowspan=1 colspan=1>Cassette Results(neg/pos)</td><td rowspan=1 colspan=1>% Agreement</td></tr><tr><td rowspan=1 colspan=1>Cutoff -25%</td><td rowspan=1 colspan=1>59/1</td><td rowspan=1 colspan=1>59/1</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>98</td></tr><tr><td rowspan=1 colspan=1>Cutoff + 25%</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>98</td></tr></table>

Tricyclic Antidepressants Bridging Study   

<table><tr><td rowspan=1 colspan=1>Concentration</td><td rowspan=1 colspan=1>Strip Results(neg/pos)</td><td rowspan=1 colspan=1>Cassette Results(neg/pos)</td><td rowspan=1 colspan=1>% Agreement</td></tr><tr><td rowspan=1 colspan=1>Cutoff -25%</td><td rowspan=1 colspan=1>60/0</td><td rowspan=1 colspan=1>58/2</td><td rowspan=1 colspan=1>97</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>98</td></tr><tr><td rowspan=1 colspan=1>Cutoff + 25%</td><td rowspan=1 colspan=1>1/59</td><td rowspan=1 colspan=1>0/60</td><td rowspan=1 colspan=1>98</td></tr></table>

b. Linearity/assay reportable range: Not applicable. The assay is intended for qualitative use.

c. Traceability (controls, calibrators, or method):

This device has an internal process control. A colored line appearing in the control region confirms that sufficient sample volume has traveled along the strip and that the membrane is intact. Users are informed that the test is invalid if a colored line fails to appear in the control region. External controls are not supplied with this device; however, users are instructed to follow federal, state, and local guidelines when determining when to run external controls.

# d. Detection limit:

Sensitivity of this assay is characterized by validating performance around the claimed cutoff concentration of the assay, including a determination of the lowest concentration of drug that is capable of producing a positive result. This information appears in the precision section, above.

# e. Analytical specificity:

Cross-reactivity was established by spiking various concentrations of similarly structured drug compounds into drug-free urine /a negative control. By analyzing various concentration of each compound the sponsor determined the concentration of the drug that produced a response approximately equivalent to the cutoff concentration of the assay. Results of those studies appear in the table(s) below:

# Amphetamine

<table><tr><td rowspan=1 colspan=1>Drug Compound</td><td rowspan=1 colspan=1>Response equivalent tocutoff in ng/mL</td></tr><tr><td rowspan=1 colspan=1>d,1-3,4-Methylenedioxymethamphetamine(MDMA)</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>d-amphetamine</td><td rowspan=1 colspan=1>1,000</td></tr><tr><td rowspan=1 colspan=1>d-methamphetamine</td><td rowspan=1 colspan=1>1,000</td></tr><tr><td rowspan=1 colspan=1>3,4-Methylenedioxyethylamphetamine(MDEA)</td><td rowspan=1 colspan=1>2,000</td></tr><tr><td rowspan=1 colspan=1>dl-amphetamine</td><td rowspan=1 colspan=1>3,000</td></tr><tr><td rowspan=1 colspan=1>Phentermine</td><td rowspan=1 colspan=1>3,000</td></tr><tr><td rowspan=1 colspan=1>1-methamphetamine</td><td rowspan=1 colspan=1>3,000</td></tr><tr><td rowspan=1 colspan=1>3,4-Methylenedioxyamphetamine (MDA)</td><td rowspan=1 colspan=1>5,000</td></tr><tr><td rowspan=1 colspan=1>l-amphetamine</td><td rowspan=1 colspan=1>50,000</td></tr></table>

Methamphetamine   

<table><tr><td rowspan=1 colspan=1>Drug Compound</td><td rowspan=1 colspan=1>Response equivalent tocutoff in ng/mL</td></tr><tr><td rowspan=1 colspan=1>3,4-Methylenedioxyethylamphetamine(MDEA)</td><td rowspan=1 colspan=1>600</td></tr><tr><td rowspan=1 colspan=1>d-methamphetamine</td><td rowspan=1 colspan=1>1,000</td></tr><tr><td rowspan=1 colspan=1>D,L 3,4-Methylenedioxymethamphetamine(MDMA)</td><td rowspan=1 colspan=1>2,000</td></tr><tr><td rowspan=1 colspan=1>3,4-Methylenedioxyamphetamine (MDA)</td><td rowspan=1 colspan=1>3,000</td></tr><tr><td rowspan=1 colspan=1>l-methamphetamine</td><td rowspan=1 colspan=1>8,000</td></tr><tr><td rowspan=1 colspan=1>trimethobenzamide</td><td rowspan=1 colspan=1>10,000</td></tr><tr><td rowspan=1 colspan=1>d-amphetamine</td><td rowspan=1 colspan=1>50,000</td></tr><tr><td rowspan=1 colspan=1>l-amphetamine</td><td rowspan=1 colspan=1>50,000</td></tr><tr><td rowspan=1 colspan=1>β-phenylethylamine</td><td rowspan=1 colspan=1>50,000</td></tr><tr><td rowspan=1 colspan=1>chloroquine</td><td rowspan=1 colspan=1>50,000</td></tr><tr><td rowspan=1 colspan=1>ephedrine</td><td rowspan=1 colspan=1>50,000</td></tr></table>

MDMA   

<table><tr><td rowspan=1 colspan=1>Drug Compound</td><td rowspan=1 colspan=1>Response equivalent tocutoff in ng/mL</td></tr><tr><td rowspan=1 colspan=1>3,4-Methylenedioxyethylamphetamine(MDEA)</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>D,L 3,4-Methylenedioxymethamphetamine(MDMA)</td><td rowspan=1 colspan=1>500</td></tr><tr><td rowspan=1 colspan=1>3,4-Methylenedioxyamphetamine (MDA)</td><td rowspan=1 colspan=1>3,000</td></tr><tr><td rowspan=1 colspan=1>d-methamphetamine</td><td rowspan=1 colspan=1>8,000</td></tr><tr><td rowspan=1 colspan=1>1-methamphetamine</td><td rowspan=1 colspan=1>10,000</td></tr><tr><td rowspan=1 colspan=1>d-amphetamine</td><td rowspan=1 colspan=1>50,000</td></tr><tr><td rowspan=1 colspan=1>l-amphetamine</td><td rowspan=1 colspan=1>60,000</td></tr></table>

Morphine (cutoff $\mathbf { 3 0 0 \ n g / m L }$   

<table><tr><td rowspan=1 colspan=1>Drug compound</td><td rowspan=1 colspan=1>Response equivalent tocutoff in ng/mL</td></tr><tr><td rowspan=1 colspan=1>Codeine</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Heroin</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Ethylmorphine</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>6-monoacetylmorphine</td><td rowspan=1 colspan=1>400</td></tr><tr><td rowspan=1 colspan=1>Morphine-3-β-glucuronide</td><td rowspan=1 colspan=1>1,000</td></tr><tr><td rowspan=1 colspan=1>Hydrocodone</td><td rowspan=1 colspan=1>5,000</td></tr><tr><td rowspan=1 colspan=1>Hydromorphone</td><td rowspan=1 colspan=1>5,000</td></tr><tr><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>30,000</td></tr><tr><td rowspan=1 colspan=1>Thebaine</td><td rowspan=1 colspan=1>30,000</td></tr></table>

Opiates (cutoff 1000 ng/mL)   

<table><tr><td rowspan=1 colspan=1>Drug compound</td><td rowspan=1 colspan=1>Response equivalent tocutoff in ng/mL</td></tr><tr><td rowspan=1 colspan=1>Codeine</td><td rowspan=1 colspan=1>2,000</td></tr><tr><td rowspan=1 colspan=1>Heroin</td><td rowspan=1 colspan=1>2,000</td></tr><tr><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>2,000</td></tr><tr><td rowspan=1 colspan=1>Morphine-3-β-glucuronide</td><td rowspan=1 colspan=1>2,000</td></tr><tr><td rowspan=1 colspan=1>6-monoacetylmorphine</td><td rowspan=1 colspan=1>5,000</td></tr><tr><td rowspan=1 colspan=1>Hydromorphone</td><td rowspan=1 colspan=1>5,000</td></tr><tr><td rowspan=1 colspan=1>Ethylmorphine</td><td rowspan=1 colspan=1>5,000</td></tr><tr><td rowspan=1 colspan=1>Hydrocodone</td><td rowspan=1 colspan=1>12,500</td></tr><tr><td rowspan=1 colspan=1>Norcodeine</td><td rowspan=1 colspan=1>12,500</td></tr><tr><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>25,000</td></tr><tr><td rowspan=1 colspan=1>Normorphone</td><td rowspan=1 colspan=1>50,000</td></tr><tr><td rowspan=1 colspan=1>Levorphanol</td><td rowspan=1 colspan=1>75,000</td></tr><tr><td rowspan=1 colspan=1>Thebaine</td><td rowspan=1 colspan=1>100,000</td></tr><tr><td rowspan=1 colspan=1>Procaine</td><td rowspan=1 colspan=1>150,000</td></tr></table>

# Cocaine

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>Response equivalent tocutoff in ng/mL</td></tr><tr><td rowspan=1 colspan=1>Benzoylecogonine</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Cocaine HCl</td><td rowspan=1 colspan=1>750</td></tr><tr><td rowspan=1 colspan=1>Cocaethylene</td><td rowspan=1 colspan=1>12,500</td></tr><tr><td rowspan=1 colspan=1>Ecgonine</td><td rowspan=1 colspan=1>32,000</td></tr></table>

# Cannabinoids (THC)

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>Response equivalent tocutoff in ng/mL</td></tr><tr><td rowspan=1 colspan=1>11-Nor-Δ8-Tetrahydrocannabinol carboxylic acid</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=1 colspan=1>11-Nor-Δ°-Tetrahydrocannabinol carboxylic acid</td><td rowspan=1 colspan=1>50</td></tr><tr><td rowspan=1 colspan=1>11-Hydroxy-∆°-Tetrahydrocannabinol</td><td rowspan=1 colspan=1>2,500</td></tr><tr><td rowspan=1 colspan=1>∆8-Tetrahydrocannabinol</td><td rowspan=1 colspan=1>7,500</td></tr><tr><td rowspan=1 colspan=1>Δ9 Tetrahydrocannabinol</td><td rowspan=1 colspan=1>10,000</td></tr><tr><td rowspan=1 colspan=1>Cannabinol</td><td rowspan=1 colspan=1>10,000</td></tr><tr><td rowspan=1 colspan=1>Cannabidiol</td><td rowspan=1 colspan=1>100,000</td></tr></table>

# Phencyclidine

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>Response equivalent tocutoff in ng/mL</td></tr><tr><td rowspan=1 colspan=1>Phencyclidine</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Phencyclidine Morpholine</td><td rowspan=1 colspan=1>50</td></tr><tr><td rowspan=1 colspan=1>4-hydroxyphencyclidine</td><td rowspan=1 colspan=1>12,500</td></tr></table>

# Barbiturates

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>Response equivalent tocutoff in ng/mL</td></tr><tr><td rowspan=1 colspan=1>Butabarbital</td><td rowspan=1 colspan=1>75</td></tr><tr><td rowspan=1 colspan=1>Phenobarbital</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Butethal</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Alphenol</td><td rowspan=1 colspan=1>150</td></tr><tr><td rowspan=1 colspan=1>Aprobarbital</td><td rowspan=1 colspan=1>200</td></tr><tr><td rowspan=1 colspan=1>Secobarbital</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Pentobarbital</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Amobarbital</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Cyclopentobarbital</td><td rowspan=1 colspan=1>600</td></tr><tr><td rowspan=1 colspan=1>Butalbital</td><td rowspan=1 colspan=1>2,500</td></tr></table>

Benzodiazepines   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>Response equivalent tocutoff in ng/mL</td></tr><tr><td rowspan=1 colspan=1>Nitrazepam</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Clobazam</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Temazepam</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Alprazolam</td><td rowspan=1 colspan=1>200</td></tr><tr><td rowspan=1 colspan=1>Diazepam</td><td rowspan=1 colspan=1>200</td></tr><tr><td rowspan=1 colspan=1>Clorazepate dipotassium</td><td rowspan=1 colspan=1>200</td></tr><tr><td rowspan=1 colspan=1>Norchlordiazepoxide</td><td rowspan=1 colspan=1>200</td></tr><tr><td rowspan=1 colspan=1>Oxazepam</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Flunitrazepam</td><td rowspan=1 colspan=1>400</td></tr><tr><td rowspan=1 colspan=1>Nordiazepam</td><td rowspan=1 colspan=1>400</td></tr><tr><td rowspan=1 colspan=1>Clonazepam</td><td rowspan=1 colspan=1>800</td></tr><tr><td rowspan=1 colspan=1>Chlordiaepoxide</td><td rowspan=1 colspan=1>1,500</td></tr><tr><td rowspan=1 colspan=1>Lorazepam</td><td rowspan=1 colspan=1>1,500</td></tr><tr><td rowspan=1 colspan=1>α  hydroxyalprazolam</td><td rowspan=1 colspan=1>1,500</td></tr><tr><td rowspan=1 colspan=1>Bromazepam</td><td rowspan=1 colspan=1>1,500</td></tr><tr><td rowspan=1 colspan=1>Delorazepam</td><td rowspan=1 colspan=1>1,500</td></tr><tr><td rowspan=1 colspan=1>Estazolam</td><td rowspan=1 colspan=1>2,500</td></tr><tr><td rowspan=1 colspan=1>Trazolam</td><td rowspan=1 colspan=1>2,500</td></tr><tr><td rowspan=1 colspan=1>Midazolam</td><td rowspan=1 colspan=1>12,500</td></tr></table>

Methadone   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>Response equivalent tocutoff in ng/mL</td></tr><tr><td rowspan=1 colspan=1>Methadone</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Doxylamine</td><td rowspan=1 colspan=1>50,000</td></tr></table>

# Tricyclic Antidepressants (TCA)

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>Response equivalent tocutoff in ng/mL</td></tr><tr><td rowspan=1 colspan=1>Desipramine</td><td rowspan=1 colspan=1>200</td></tr><tr><td rowspan=1 colspan=1>Imipramine</td><td rowspan=1 colspan=1>400</td></tr><tr><td rowspan=1 colspan=1>Nortriptyline</td><td rowspan=1 colspan=1>1,000</td></tr><tr><td rowspan=1 colspan=1>Nordoxepine</td><td rowspan=1 colspan=1>1,000</td></tr><tr><td rowspan=1 colspan=1>Amitriptyline</td><td rowspan=1 colspan=1>1,500</td></tr><tr><td rowspan=1 colspan=1>Promazine</td><td rowspan=1 colspan=1>1,500</td></tr><tr><td rowspan=1 colspan=1>Doxepine</td><td rowspan=1 colspan=1>2,000</td></tr><tr><td rowspan=1 colspan=1>Maprotiline</td><td rowspan=1 colspan=1>2,000</td></tr><tr><td rowspan=1 colspan=1>Trimipramine</td><td rowspan=1 colspan=1>3,000</td></tr><tr><td rowspan=1 colspan=1>Clomipramine</td><td rowspan=1 colspan=1>12,500</td></tr><tr><td rowspan=1 colspan=1>Promethazine</td><td rowspan=1 colspan=1>25,000</td></tr></table>

To evaluate for interference the sponsor prepared three control samples for all 12 analytes: drug-free urine, drug-free urine spiked to an analyte concentration $50 \%$ below the cutoff, and drug-free urine spiked to an analyte concentration $50 \%$ above the cutoff of the targeted drug. 100 $\mu \mathrm { g / m L }$ of potentially interfering compounds were then added to separate aliquots of the control samples and analyzed. There were no deviations from the expected results; i.e., the drug-free and cutoff – $50 \%$ samples all read negative, and the cutoff $+ 5 0 \%$ sample all read positive. All of the compounds tested are listed in the package inserts.

There is the possibility that other substances and/or factors not listed above may interfere with the test and cause false results, e.g., technical or procedural errors.

To test for potential positive and negative interference from endogenous conditions the sponsor prepared two control samples, one with drug-free urine spiked to an analyte concentration $50 \%$ below the cutoff, and one with drug-free urine spiked to $50 \%$ above the cutoff of the targeted drug. Aliquots of the control samples were then altered to span the following ranges of conditions, and analyzed:

$4 { \cdot } 9 \mathrm { p H }$ 1.000 to 1.035 specific gravity

There was no change in test results as compared to the results of the control sample. The sponsor did not evaluate the effects albumin on the assay.

$f .$ Assay cut-off:

Of the 12 analytes in this submission, six use cutoffs recommended for use by the Substance Abuse and Mental Health Services Administration (SAMHSA): cannabinoids, cocaine, opiates, phencyclidine, amphetamines, and MDMA (methylenedioxymethamphetamine). SAMHSA has not recommended cutoff concentrations for the other six analytes.

Characterization of how the device performs analytically around the claimed cutoff concentration appears in the precision section, above.

2. Comparison studies:

a. Method comparison with predicate device: Because the candidate device was compared to a reference method, GC/MS, it was not compared to a predicate device.

Sample description: Unaltered clinical urine samples were evaluated. A portion of samples having drug concentrations that were below the cutoff concentration of the assay were also evaluated by GC/MS.

The study included an adequate number of samples that contained drugs near to the cutoff concentration of the assay. Approximately $40 \%$ of the study samples are evenly distributed between plus and minus $50 \%$ of the claimed cutoff concentration.

Number of study sites: one Type of study site: Manufacturer’s facility Operator description: Manufacturer’s staff

# Candidate Device Results vs. stratified GC/MS Values - Amphetamine

A total of 80 samples (40 negative and 40 positive) were evaluated by the candidate device and by GC/MS. Each test device was read by three readers.

# Reader A

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 4</td><td>concentration) 11</td><td>29</td></tr><tr><td>Negative</td><td>28</td><td>8</td><td>0</td><td>0</td></tr></table>

$\%$ Agreement among positives is $100 \%$ $\%$ Agreement among negatives is $90 \%$

# Reader B

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 1</td><td>concentration) 11</td><td>29</td></tr><tr><td>Negative</td><td>28</td><td>11</td><td>0</td><td>0</td></tr></table>

$\%$ Agreement among positives is $100 \%$ $\%$ Agreement among negatives is $9 8 \%$

Reader C   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 5</td><td>concentration) 11</td><td>29</td></tr><tr><td>Negative</td><td>28</td><td>7</td><td>0</td><td>0</td></tr></table>

$\%$ Agreement among positives is $100 \%$ $\%$ Agreement among negatives is $8 8 \%$

GC/MS values used to categorize samples in these tables are based on the concentration of d-amphetamine found in the sample.

# Candidate Device Results vs. stratified GC/MS Values – Barbiturate

A total of 80 samples (40 negative and 40 positive) were evaluated by the candidate device and by GC/MS. Each test device was read by three readers.

# Reader A

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 4</td><td>concentration) 15</td><td>20</td></tr><tr><td>Negative</td><td>20</td><td>16</td><td>5</td><td>0</td></tr></table>

$\%$ Agreement among positives is $8 8 \%$ $\%$ Agreement among negatives is $90 \%$

Reader B   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 2</td><td>concentration) 18</td><td>20</td></tr><tr><td>Negative</td><td>20</td><td>18</td><td>2</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 5 \%$ $\%$ Agreement among negatives is $9 5 \%$

Reader C   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 3</td><td>concentration) 18</td><td>20</td></tr><tr><td>Negative</td><td>20</td><td>17</td><td>2</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 5 \%$ $\%$ Agreement among negatives is $93 \%$

GC/MS values used to categorize samples in these tables are based on the concentration of secobarbital found in the sample.

# Candidate Device Results vs. stratified GC/MS Values - Benzodiazepines

A total of 80 samples (40 negative and 40 positive) were evaluated by the candidate device and by GC/MS. Each test device was read by three readers.

# Reader A

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 2</td><td>concentration) 17</td><td>20</td></tr><tr><td>Negative</td><td>20</td><td>18</td><td>3</td><td>0</td></tr></table>

$\%$ Agreement among positives is $93 \%$ $\%$ Agreement among negatives is $9 5 \%$

Reader B   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 1</td><td>concentration) 20</td><td>20</td></tr><tr><td>Negative</td><td>20</td><td>19</td><td>0</td><td>0</td></tr></table>

$\%$ Agreement among positives is $100 \%$ $\%$ Agreement among negatives is $9 8 \%$

Reader C   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 3</td><td>concentration) 18</td><td>20</td></tr><tr><td>Negative</td><td>20</td><td>17</td><td>2</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 5 \%$ $\%$ Agreement among negatives is $93 \%$

GC/MS values used to categorize samples in these tables are based on the concentration of oxazepam found in the sample.

# Candidate Device Results vs. stratified GC/MS Values - Cocaine

A total of 80 samples (40 negative and 40 positive) were evaluated by the candidate device and by GC/MS. Each test device was read by three readers.

# Reader A

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 1</td><td>concentration) 11</td><td>29</td></tr><tr><td>Negative</td><td>20</td><td>19</td><td>0</td><td>0</td></tr></table>

$\%$ Agreement among positives is $100 \%$ $\%$ Agreement among negatives is $9 8 \%$

Reader B   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 1</td><td>concentration) 9</td><td>29</td></tr><tr><td>Negative</td><td>20</td><td>19</td><td>2</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 5 \%$ $\%$ Agreement among negatives is $9 8 \%$

Reader C   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 2</td><td>concentration) 9</td><td>29</td></tr><tr><td>Negative</td><td>20</td><td>18</td><td>2</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 5 \%$ $\%$ Agreement among negatives is $9 5 \%$

GC/MS values used to categorize samples in these tables are based on the concentration of benzoylecgonine found in the sample.

# Candidate Device Results vs. stratified GC/MS Values - Cannabinoids

A total of 80 samples (40 negative and 40 positive) were evaluated by the candidate device and by GC/MS. Each test device was read by three readers.

# Reader A

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 4</td><td>concentration) 18</td><td>22</td></tr><tr><td>Negative</td><td>22</td><td>14</td><td>0</td><td>0</td></tr></table>

$\%$ Agreement among positives is $100 \%$ $\%$ Agreement among negatives is $90 \%$

Reader B   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 0</td><td>concentration) 17</td><td>22</td></tr><tr><td>Negative</td><td>22</td><td>18</td><td>1</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 8 \%$ $\%$ Agreement among negatives is $100 \%$

Reader C   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 0</td><td>concentration) 15</td><td>22</td></tr><tr><td>Negative</td><td>22</td><td>18</td><td>3</td><td>0</td></tr></table>

$\%$ Agreement among positives is $93 \%$ $\%$ Agreement among negatives is $100 \%$

GC/MS values used to categorize samples in these tables are based on the concentration of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid found in the sample.

# Candidate Device Results vs. stratified GC/MS Values - Methadone

A total of 80 samples (40 negative and 40 positive) were evaluated by the candidate device and by GC/MS. Each test device was read by three readers.

# Reader A

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 0</td><td>concentration) 17</td><td>21</td></tr><tr><td>Negative</td><td>22</td><td>18</td><td>2</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 5 \%$ $\%$ Agreement among negatives is $100 \%$

Reader B   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 0</td><td>concentration) 18</td><td>21</td></tr><tr><td>Negative</td><td>22</td><td>18</td><td>1</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 8 \%$ $\%$ Agreement among negatives is $100 \%$

Reader C   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 0</td><td>concentration) 18</td><td>21</td></tr><tr><td>Negative</td><td>22</td><td>18</td><td>1</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 8 \%$ $\%$ Agreement among negatives is $100 \%$

GC/MS values used to categorize samples in these tables are based on the concentration of methadone found in the sample.

# Candidate Device Results vs. stratified GC/MS Values - Methamphetamine

A total of 80 samples (40 negative and 40 positive) were evaluated by the candidate device and by GC/MS. Each test device was read by three readers.

# Reader A

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff concentration)</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff concentration)</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>5</td><td>19</td><td>20</td></tr><tr><td>Negative</td><td>26</td><td>9</td><td>1</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 8 \%$ $\%$ Agreement among negatives is $8 8 \%$

Reader B   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>2</td><td>concentration) 3</td><td>concentration) 19</td><td>20</td></tr><tr><td>Negative</td><td>24</td><td>11</td><td>1</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 8 \%$ $\%$ Agreement among negatives is $8 8 \%$

Reader C   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>1</td><td>concentration) 5</td><td>concentration) 18</td><td>20</td></tr><tr><td>Negative</td><td>25</td><td>9</td><td>2</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 5 \%$ $\%$ Agreement among negatives is $8 5 \%$

GC/MS values used to categorize samples in these tables are based on the concentration of d-methamphetamine found in the sample.

# Candidate Device Results vs. stratified GC/MS Values - MDMA

A total of 80 samples (40 negative and 40 positive) were evaluated by the candidate device and by GC/MS. Each test device was read by three readers.

# Reader A

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 0</td><td>concentration) 19</td><td>20</td></tr><tr><td>Negative</td><td>20</td><td>20</td><td>1</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 8 \%$ $\%$ Agreement among negatives is $100 \%$

Reader B   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 3</td><td>concentration) 19</td><td>20</td></tr><tr><td>Negative</td><td>20</td><td>17</td><td>1</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 8 \%$ $\%$ Agreement among negatives is $93 \%$

Reader C   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 2</td><td>concentration) 19</td><td>20</td></tr><tr><td>Negative</td><td>20</td><td>18</td><td>1</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 8 \%$ $\%$ Agreement among negatives is $9 5 \%$

GC/MS values used to categorize samples in these tables are based on the concentration of d,l -3,4-Methylenedioxymethamphetamine (MDMA) found in the sample.

# Candidate Device Results vs. stratified GC/MS Values - Morphine

A total of 80 samples (40 negative and 40 positive) were evaluated by the candidate device and by GC/MS. Each test device was read by three readers.

# Reader A

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 3</td><td>concentration) 19</td><td>20</td></tr><tr><td>Negative</td><td>29</td><td>8</td><td>1</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 8 \%$ $\%$ Agreement among negatives is $93 \%$

Reader B   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 3</td><td>concentration) 19</td><td>20</td></tr><tr><td>Negative</td><td>29</td><td>8</td><td>1</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 8 \%$ $\%$ Agreement among negatives is $93 \%$

Reader C   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 4</td><td>concentration) 19</td><td>20</td></tr><tr><td>Negative</td><td>29</td><td>7</td><td>1</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 8 \%$ $\%$ Agreement among negatives is $90 \%$

GC/MS values used to categorize samples in these tables are based on the concentration of morphine found in the sample.

# Candidate Device Results vs. stratified GC/MS Values - Opiate

A total of 80 samples (40 negative and 40 positive) were evaluated by the candidate device and by GC/MS. Each test device was read by three readers.

# Reader A

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 2</td><td>concentration) 16</td><td>22</td></tr><tr><td>Negative</td><td>30</td><td>8</td><td>2</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 5 \%$ $\%$ Agreement among negatives is $9 5 \%$

Reader B   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 1</td><td>concentration) 17</td><td>22</td></tr><tr><td>Negative</td><td>30</td><td>9</td><td>1</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 8 \%$ $\%$ Agreement among negatives is $9 8 \%$

Reader C   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 1</td><td>concentration) 16</td><td>22</td></tr><tr><td>Negative</td><td>30</td><td>9</td><td>2</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 5 \%$ $\%$ Agreement among negatives is $9 8 \%$

GC/MS values used to categorize samples in these tables are based on the concentration of morphine found in the sample.

# Candidate Device Results vs. stratified GC/MS Values - Phencyclidine

A total of 80 samples (40 negative and 40 positive) were evaluated by the candidate device and by GC/MS. Each test device was read by three readers.

# Reader A

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 0</td><td>concentration) 15</td><td>22</td></tr><tr><td>Negative</td><td>23</td><td>17</td><td>3</td><td>0</td></tr></table>

$\%$ Agreement among positives is $93 \%$ $\%$ Agreement among negatives is $100 \%$

Reader B   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 0</td><td>concentration) 17</td><td>22</td></tr><tr><td>Negative</td><td>23</td><td>17</td><td>1</td><td>0</td></tr></table>

$\%$ Agreement among positives is $9 8 \%$ $\%$ Agreement among negatives is $100 \%$

Reader C   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 1</td><td>concentration) 15</td><td>22</td></tr><tr><td>Negative</td><td>23</td><td>16</td><td>3</td><td>0</td></tr></table>

$\%$ Agreement among positives is $93 \%$ $\%$ Agreement among negatives is $9 8 \%$

GC/MS values used to categorize samples in these tables are based on the concentration of phencyclidine found in the sample.

# Candidate Device Results vs. stratified GC/MS Values - TCA

A total of 80 samples (40 negative and 40 positive) were evaluated by the candidate device and by GC/MS. Each test device was read by three readers.

# Reader A

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 0</td><td>concentration) 10</td><td>30</td></tr><tr><td>Negative</td><td>29</td><td>11</td><td>0</td><td>0</td></tr></table>

$\%$ Agreement among positives is $100 \%$ $\%$ Agreement among negatives is $100 \%$

Reader B   

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 2</td><td>concentration) 10</td><td>30</td></tr><tr><td>Negative</td><td>29</td><td>9</td><td>0</td><td>0</td></tr></table>

$\%$ Agreement among positives is $100 \%$ $\%$ Agreement among negatives is $9 5 \%$

# Reader C

<table><tr><td>Candidate Device Results</td><td>Less than half the cutoff concentration by GC/MS analysis</td><td>Near Cutoff Negative (Between 50% below the cutoff and the cutoff</td><td>Near Cutoff Positive (Between the cutoff and 50% above the cutoff</td><td>High Positive (greater than 50% above the cutoff concentration)</td></tr><tr><td>Positive</td><td>0</td><td>concentration) 0</td><td>concentration) 10</td><td>30</td></tr><tr><td>Negative</td><td>29</td><td>11</td><td>0</td><td>0</td></tr></table>

$\%$ Agreement among positives is $100 \%$ $\%$ Agreement among negatives is $100 \%$

GC/MS values used to categorize samples in these tables are based on the concentration of nortriptyline found in the sample.

b. Matrix comparison: Not applicable. The assay is intended for only one sample matrix.

# 3. Clinical studies:

a. Clinical sensitivity: Not applicable. Clinical studies are not typically submitted for this device type.   
b. Clinical specificity: Not applicable. Clinical studies are not typically submitted for this device type.   
c. Other clinical supportive data (when a and b are not applicable):   
4. Clinical cut-off: Not applicable.   
5. Expected values/Reference range: Not applicable.

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.